Prepare Yourself for Liftoff: CorMedix Inc (CRMD)

With 1.58 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.05 million shares. The 52-week range on CRMD shows that it touched its highest point at $13.85 and its lowest point at $3.03 during that stretch. It currently has a 1-year price target of $17.00. Beta for the stock currently stands at 1.41.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRMD was up-trending over the past week, with a rise of 3.38%, but this was up by 0.28% over a month. Three-month performance surged to 8.73% while six-month performance rose 86.59%. The stock gained 201.69% in the past year, while it has gained 32.22% so far this year. A look at the trailing 12-month EPS for CRMD yields -0.80 with Next year EPS estimates of 0.53. For the next quarter, that number is 0.13. This implies an EPS growth rate of 57.77% for this year and 238.29% for next year.

Float and Shares Shorts:

At present, 60.68 million CRMD shares are outstanding with a float of 59.25 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRMD since 2 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.35291 being high and -$0.45636 being low. For CRMD, this leads to a yearly average estimate of -$0.38429. Based on analyst estimates, the high estimate for the next quarter is $0.22 and the low estimate is $0.08. The average estimate for the next quarter is thus $0.16.